Pancreatic Cancer Research

ResearcherWashington University in St. LouisActive in the last 2 years

Zhongren Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6977-8414; OpenAlex author ID A5044137274. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Hypoxia-induced metastatic heterogeneity in pancreatic cancer. Co-author DOI 10.1038/s41467-026-76143-w↗
  2. Phosphomannose Isomerase High Expression Associated with Better Prognosis in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.2147/ceg.s316492↗
  3. Comparison of programmed death ligand 1 immunostaining for pancreatic ductal adenocarcinoma between paired cytological and surgical samples. Last author DOI 10.25259/cytojournal_78_2020↗
  4. Incidence and Significance of GATA3 Positivity in Pancreatic Ductal Adenocarcinoma and Cholangiocarcinoma. Co-author DOI 10.1097/pai.0000000000000764↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Raul S. González · 2 shared papers, 2020–2021 · strength 0.25
  2. Diana Agostini‐Vulaj · 2 shared papers, 2020–2021 · strength 0.25
  3. Michael Muggilli · 1 shared paper, 2021 · strength 0.22
  4. Shin‐Heng Chiou · 1 shared paper, 2026 · strength 0.21
  5. Pradeep Moon Gunasekaran · 1 shared paper, 2026 · strength 0.21
  6. Zahra Alipour · 1 shared paper, 2021 · strength 0.14
  7. Richard Francis Dunne · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.